Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer

This study is currently recruiting participants. (see Contacts and Locations)

Verified July 2016 by City of Hope Medical Center

Sponsor:

Collaborator:

National Cancer Institute (NCI)

Information provided by (Responsible Party):

City of Hope Medical Center

ClinicalTrials.gov Identifier:

NCT01525966

First received: January 27, 2012

Last updated: July 14, 2016

Last verified: July 2016

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	May 2017 (Final data collection date for primary outcome measure)